COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Noema Pharma is a Basel-based clinical-stage biotech that in-licensed four Roche CNS assets and operates multiple Phase 2/2b programs—mGluR5, PDE10A, mGlu2/3, and triple-reuptake modulators—for neurological and related disorders.
